Article contents
Epidemiological profile, as determined by the frax tool, of patients with type 1 diabetes mellitus followed at a referral hospital in Belém
Abstract
This study evaluated the FRAX tool as a screening strategy for osteoporotic fractures in people with type 1 diabetes mellitus (T1DM), in comparison with bone mineral densitometry. It also described the epidemiological profile of these patients. This was an observational, cross-sectional study conducted at the Endocrinology Outpatient Clinic of the João de Barros Barreto University Hospital in Belém, Pará, Brazil. The sample comprised 15 patients with T1DM aged 40–90 years. Patients were excluded if they had secondary or previously diagnosed osteoporosis, were undergoing osteoporosis treatment or chronic corticosteroid therapy, or had advanced chronic kidney disease. A standardized questionnaire gathered demographic, anthropometric, clinical, family history, and laboratory data. The 10-year fracture risk was estimated with two versions of FRAX (ABRASSO and University of Sheffield), and bone densitometry results were analyzed when available. Mean age was 48 years, 60% of participants were female, and mean BMI was 28.8, with 80% overweight or obese. Mean diabetes duration was 25 years. Diabetes complications affected 80% of patients, with retinopathy, hypertension, and nephropathy each present in 46%. A personal history of fractures was reported by 33% and a family history of fractures by 53%. Mean fasting glucose was 144 mg/dL and mean HbA1c was 9.75%, indicating inadequate glycemic control. According to the University of Sheffield FRAX, 93% of participants were low risk and 7% intermediate risk. According to the ABRASSO FRAX, 80% of the patients who could be assessed were intermediate risk. Densitometry was available for only three participants and varied widely, including one case of spinal osteoporosis. The sample showed a long disease course, poor glycemic control, and multiple risk factors for fractures. The discrepancy between the two FRAX versions suggests possible underestimation of fracture risk in T1DM (Sheffield) or overestimation (ABRASSO). The low incidence of T1DM, the small sample, and the few densitometry results limit the conclusions. Larger studies are needed to confirm the usefulness of FRAX in this population.
Aims & scope
Call for Papers
Article Processing Charges
Publications Ethics
Google Scholar Citations
Recruitment